CD44v6V600EBRAF

A C L Mortensen1,2, J Imgenberg-Kreuz3, D Spiegelberg1,4

  • 1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden.

Heliyon
|December 11, 2023
PubMed
概括

使用CD44v6抗体和索拉费尼布的向治疗对形甲状腺癌 (ATC) 有希望. 组合疗法显著损害了瘤球状体的生长,这表明分子放射治疗的潜力.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K